TOFUMA 5 MG (Tofacitinib (5mg))

Tofuma 5mg Tablet is indicated for the management of moderate to severe rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis. This medication works by alleviating pain, tenderness, and inflammation in the joints, thereby reducing swelling and helping to prevent further damage to bones and joints. It may be prescribed alone or in conjunction with other medications, depending on the specific needs of the patient. Tofuma tablets can be ingested with or without food, and it is advisable to take them consistently at the same time each day to maintain stable levels in the body. The dosage prescribed will be tailored to the individual’s health condition and any other medications being taken. It is crucial to follow your healthcare provider’s instructions regarding usage, and discontinuation should only occur under medical supervision, as stopping abruptly may lead to a worsening of symptoms. Prior to starting Tofuma, patients may require blood tests, and it’s essential not to initiate treatment if there is an existing infection. It is important to inform your physician if there is a history of tuberculosis, shingles, kidney or liver disease, or blood clotting disorders. This medication can increase susceptibility to infections, so it is advisable to avoid exposure to individuals with communicable diseases. Tofuma is not recommended for use in individuals under 18 years of age, nor should it be used during pregnancy or breastfeeding unless the healthcare professional determines the benefits justify the risks. Regular monitoring by a healthcare provider may be necessary throughout treatment.